tobramycin has been researched along with Skin Diseases, Bacterial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afifi, A; De Lord, D; Rasool, S | 1 |
| Biswas, A; Cadwgan, A; Halpern, J; Tan, BB | 1 |
| Bes, M; Cavalié, L; Decousser, JW; Etienne, J; Laurent, F; Robert, J; Tristan, A | 1 |
3 other study(ies) available for tobramycin and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Case of atypical cutaneous
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2019 |
Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tobramycin; Treatment Outcome | 2010 |
Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Community-Acquired Infections; Enterotoxins; Exotoxins; France; Humans; Kanamycin; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Superantigens; Tetracycline; Tobramycin | 2011 |